Ataxia-telangiectasia mutated (ATM) silencing promotes neuroblastoma progression through aMYCNindependent mechanism
Open Access
- 26 May 2015
- journal article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 6 (21) , 18558-18576
Abstract
Ataxia-telangiectasia mutated ( ATM ) silencing promotes neuroblastoma progression through a MYCN independent mechanism Ataxia-telangiectasia mutated (ATM) silencing promotes neuroblastoma progression through a MYCN independent mechanismKeywords
This publication has 59 references indexed in Scilit:
- Targeting MYCN in Neuroblastoma by BET Bromodomain InhibitionCancer Discovery, 2013
- Functional MYCN signature predicts outcome of neuroblastoma irrespective of MYCN amplificationProceedings of the National Academy of Sciences, 2012
- The ATM protein kinase and cellular redox signaling: beyond the DNA damage responseTrends in Biochemical Sciences, 2012
- Lymphocyte Development: Integration of DNA Damage Response Signaling2012
- The essence of senescence: Figure 1.Genes & Development, 2010
- Ataxia Telangiectasia Mutated (ATM) Inhibition Transforms Human Mammary Gland Epithelial CellsJournal of Biological Chemistry, 2010
- ATM is down-regulated by N-Myc–regulated microRNA-421Proceedings of the National Academy of Sciences, 2010
- The International Neuroblastoma Risk Group (INRG) Classification System: An INRG Task Force ReportJournal of Clinical Oncology, 2009
- Two distinctly altered cellular responses to DNA double-strand breaks in human neuroblastomaBiochimie, 2008
- CADM1 is a strong neuroblastoma candidate gene that maps within a 3.72 Mb critical region of loss on 11q23BMC Cancer, 2008